Özet

Background: This study aims to evaluate the frequency of and associated risk factors for adverse events caused by cardiac catheterization procedures in pediatric patients.

Methods: Between January 2009 and January 2012, a total of 599 pediatric patients (320 males, 279 females; mean age 5.4±4.7 years; range, 1 day to 21 years) who underwent cardiac catheterization in our cardiac catheterization laboratory were retrospectively analyzed. Demographic and clinical data of the patients including the duration of the procedure, management of anesthesia, the American Society of Anesthesiologists class, and Catheterization Risk Score for Pediatrics, and procedure-related serious adverse events were recorded.

Results: The incidence of procedure-related serious adverse events was 9.18%. Potential risk factors associated with serious adverse events were identified as interventional heart catheterization, high scores obtained from the Catheterization Risk Score for Pediatrics, the use of endotracheal tube in airway control, and prolonged procedural duration.

Conclusion: Our study results suggest that prolonged duration of catheterization is a potential risk factor for procedure-related adverse events and the duration of the procedure needs to be included as a variable in the Catheterization Risk Score for Pediatrics scoring system for predicting procedure-related adverse events.

Pediatric cardiac catheterization is usually performed for the diagnosis and the interventional treatment of congenital heart diseases or hemodynamic problems.[1] However, cardiac catheterization has various potential complications. Previous studies have reported several risk factors associated with the complications during cardiac catheterization procedures.[2-9] The Catheterization Risk Score fr Pediatrics (CRISP) is commonly used to predict the risk of any serious adverse event (SAE).[10] The SAEs include any adverse event causing mortality, permanent morbidity, the need for further interventions, or the prolonged length of stay in the hospital.[10] The CRISP evaluates eight variables (i.e., age, body weight, the need for inotropic support, the presence of systemic disease/failure, physiologic category, precatheterization diagnosis, procedure risk category, and procedure type) through a web-based CRISP calculator* (Table 1)[11]

Table 1: Calculation of the risk score

In this study, we aimed to evaluate the CRISP for cardiac catheterization procedures in a pediatric heart center and to assess SAEs and associated risk factors in this patient population.

Yöntem

This retrospective, cross-sectional study included a total of 599 patients (320 males, 279 females; mean age 5.4±4.7 years; range, 1 day to 21 years) who underwent cardiac catheterization between January 2009 and January 2012. Patients whose medical files could not be accessed were excluded from the study. Demographic data, the American Society of Anesthesiologists (ASA) class, CRISP, the type of cardiac catheterization, anesthesia management, procedure duration (the duration from percutaneous catheter insertion until removal), and data regarding SAEs were obtained from the anesthesia follow-up forms of the patients. A written informed consent was obtained from each parent. The study protocol was approved by Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research Hospital Ethics Committee (No. 2017/152). The study was conducted in accordance with the principles of the Declaration of Helsinki.

The catheterization procedures were diagnostic or interventional purposes. All procedures were compared considering hybrid catheterizations as interventional procedures. All catheterization procedures were performed under sedation or inhalational general anesthesia. During sedation analgesia, airway management was provided with a natural unaided airway. During inhalational general anesthesia, airway patency was provided with an endotracheal tube (ETT), a laryngeal mask airway (LMA), or a facial mask. An intramuscular cardiological cocktail containing pheniramine maleate (45.5 mg/2 mL), chlorpromazine (25 mg/5 mL), and meperidine (100 mg/2 mL) was used at a dose of 0.1 mL/kg (up to maximum 2 mL) for the premedication in patients older than one year of age. All patients underwent non-invasive monitoring including heart rhythm, oxygen saturation (SpO₂), non-invasive blood pressure (NIBP), and RR interval every 5 min, until they left the catheterization laboratory.

Statistical analysis
Statistical analysis was performed using the IBM SPSS version 22.0 software (IBM Corp., Armonk, NY, USA). Descriptive data were expressed in mean ± standard deviation (SD), median (min-max), or number and frequency. The normality distribution of variables was assessed by the Kolmogorov-Smirnov test. In the analysis of quantitative data for independent groups, the Mann-Whitney U test was used. The chi-square test or Fischer's exact test was used in the analysis of qualitative data for independent groups. Univariate and multivariate logistic regression analyses were also done. A p value of <0.05 was considered statistically significant.

Bulgular

Of 599 patients, a total of 68 SAEs were reported in 55 patients who underwent cardiac catheterization procedures for diagnostic or interventional purposes. The overall incidence of SAEs was 9.18%.

Arrhythmia w as the most common SAE in diagnostic catheterizations, while laryngospasm was the most common SAE during interventional catheterizations. The SAEs were categorized as cardiac events, airway events, vomiting, allergic reactions, seizure, cardiac arrest, and death. Cardiac events in patients having cardiac catheterization included bradyarrhythmia, left bundle branch block, atrioventricular block, supraventricular tachyarrhythmia, ventricular tachyarrhythmia, ventricular fibrillation, Torsades de pointes, and unexpected cardiac arrest. Only one patient (0.16%), who was critically ill and required inotropic and ventilator support before catheterization, died during cardiac catheterization. Diagnostic cardiac catheterization and balloon angioplasty were planned for this patient. However, this patient died during diagnostic cardiac catheterization. The patient had cardiopulmonary arrest and did not respond to the cardiopulmonary resuscitation for more than 30 min (Table 2).

Table 2: Serious adverse events during diagnostic and interventional catheterization

The airway events such as bronchospasm, transient hypoventilation, and apnea were experienced in patients having cardiac catheterization. Transient hypoventilation and apnea were caused by an LMA shift in two patients and a deepening of sedationanalgesia in six patients. Therefore, these eight patients required bag-mask ventilation and LMA insertion. The distribution of SAEs experienced during diagnostic and interventional catheterizations is shown in Table 2.

In order to further investigate the risk factors of these SAEs, we divided the patients into two groups as those with and without SAEs. A comparison of the characteristics of patients with and without SAEs is shown in Table 3.

Table 3: Demographic and clinical characteristics of patients

Univariate and multivariate analyses revealed three independent risk factors for SAEs: procedure duration (odds ratio [OR]= 1.04, 95% confidence interval [CI]: 1.03-1.06), interventional procedure (OR= 0.21, CI: 0.07-0.56), airway control with endotracheal tube (OR= 6.25, CI: 2.92-13.42) (p<0.05) (Table 4).

Table 4: Risk factors for serious adverse events of cardiac catheterization

A comparison of the patients with and without SAEs indicated that a high CRISP score (p<0.001), airway control with ETT (p<0.001), and interventional procedure (p=0.012) were associated with the risk of SAEs. More remarkably, the duration of the procedure was significantly longer in patients with SAEs (p<0.001). The SAEs occurred in 55 patients, of whom 42 (76.4%) were operated under general anesthesia, and 13 (23.6%) were operated under sedation-analgesia. The rate of SAEs among the patients who underwent general anesthesia was higher than that of the sedated patients. The rate of airway control with ETT was significantly higher in those with SAEs.

The incidence of SAEs was analyzed in patients categorized in terms of CRISP scores. The rates of SAEs in patients with CRISP Category 1 to Category 5 were 1.37%, 11.16%, 15.52%, 16.66%, and 40%, respectively (Table 5).

Table 5: Distribution of patients with SAE according CRISP score and risk category

Tartışma

Cardiac catheterization in pediatric patients with congenital heart disease has a risk of morbidity and mortality. The reported rates of SAEs range from 6.16 to 11.3%, while mortality rates range from 0.09 to 0.22%.[2-4,6] These rates were 9.18% and 0.16%, respectively in our study.

Young age, low body weight, having interventional procedures, the requirement inotropic support during the procedure, accompanying of non-cardiac problems, low peripheral oxygen saturation, and longer procedures have previously been shown to be risk factors for SAEs.[6,12,20] In our study, multivariate analysis revealed three independent risk factors: the duration of the procedure, interventional procedure, airway control with ETT. Lin et al.[12] reported the rate of SAEs to be 0.4% in patients with whom the cardiac catheterization took less than 60 min, while the rate increased up to 0.8% in those with the duration of procedure between 60 and 180 min and 1.3% in those with a duration longer than 180 min. The duration of procedure was also demonstrated to be a risk factor by Bergersen et al.[21] who reported that the risk of SAEs significantly increased, when the duration of the procedure for cardiac catheterization was longer than 60 min. These authors found that the rate of SAEs was 6% when the duration was less than 60 min; 15% when the duration was between 60 and 120 min; 31% when it was between 120 and 180 min; and 38% when it was longer than 180 min.

The risk of SAEs may increase due to prolonged duration of procedure in interventional catheterization.[2-4,6,7,12,21,22] Several studies have demonstrated that SAEs are more frequent during intervention procedures, particularly with aortic valve dilatation, atrial septostomy, and balloon interventions.[2,4,6,23-26]

Applying the positive intrathoracic pressure (during ETT) in controlled ventilation induces undesired inferior vena cava compression, which reduces venous return for the preload. The ETT application is, therefore, considered a potential risk factor compared to the facemask.[13,18] Flick et al.[18] found that the use of ETT was riskier for the development of laryngospasm. A study focusing on the perioperative morbidity in pediatric anesthesia reported that complications were more frequent in patients who underwent endotracheal intubation.[13] Likewise, our findings indicated that the rate of complications was higher in the intubated patients, compared to the patients managed with other airway devices.

The main limitation of our study was its retrospective and single-center design.

In conclusion, the Catheterization Risk Score for Pediatrics accurately predicts procedural risk, and an extended procedure time is a crucial risk factor, irrespective of the type of catheterization (i.e., diagnostic or interventional) or anesthesia. Therefore, time matters in a catheterization laboratory. Nonetheless, multi-center, large-scale, long-term prospective studies are needed to confirm these findings.

Declaration of conflicting interests
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Funding
The authors received no financial support for the research and/or authorship of this article.

Kaynaklar

1) Lam JE, Lin EP, Alexy R, Aronson LA. Anesthesia and the pediatric cardiac catheterization suite: a review. Paediatr Anaesth 2015;25:127-34.

2) Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998;32:1433-40.

3) Bennett D, Marcus R, Stokes M. Incidents and complications during pediatric cardiac catheterization. Paediatr Anaesth 2005;15:1083-8.

4) Mehta R, Lee KJ, Chaturvedi R, Benson L. Complications of pediatric cardiac catheterization: a review in the current era. Catheter Cardiovasc Interv 2008;72:278-85.

5) Ramamoorthy C, Haberkern CM, Bhananker SM, Domino KB, Posner KL, Campos JS, et al. Anesthesia-related cardiac arrest in children with heart disease: data from the Pediatric Perioperative Cardiac Arrest (POCA) registry. Anesth Analg 2010;110:1376-82.

6) Yilmazer MM, Ustyol A, Güven B, Oner T, Demirpençe S, Doksöz O, et al. Complications of cardiac catheterization in pediatric patients: a single center experience. Turk J Pediatr 2012;54:478-85.

7) Odegard KC, Bergersen L, Thiagarajan R, Clark L, Shukla A, Wypij D, et al. The frequency of cardiac arrests in patients with congenital heart disease undergoing cardiac catheterization. Anesth Analg 2014;118:175-82.

8) Kogan A, Efrat R, Katz J, Vidne BA. Propofol-ketamine mixture for anesthesia in pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2003;17:691-3.

9) Williams GD, Maan H, Ramamoorthy C, Kamra K, Bratton SL, Bair E, et al. Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine. Paediatr Anaesth 2010;20:28-37.

10) Nykanen DG, Forbes TJ, Du W, Divekar AA, Reeves JH, Hagler DJ, et al. CRISP: Catheterization RISk score for Pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC). Catheter Cardiovasc Interv 2016;87:302-9.

11) Catheterization RISk Score for Pediatrics. Available at: http:// www.pmidcalc.org/?sid=26527119&newtest=Y. [Accessed: November 3, 2019].

12) Lin CH, Desai S, Nicolas R, Gauvreau K, Foerster S, Sharma A, et al. Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter Experience. Pediatr Cardiol 2015;36:1363-75.

13) Murat I, Constant I, Maud'huy H. Perioperative anaesthetic morbidity in children: a database of 24,165 anaesthetics over a 30-month period. Paediatr Anaesth 2004;14:158-66.

14) Warner MA, Lunn RJ, O'Leary PW, Schroeder DR. Outcomes of noncardiac surgical procedures in children and adults with congenital heart disease. Mayo Perioperative Outcomes Group. Mayo Clin Proc 1998;73:728-34.

15) Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007;104:521-7.

16) Rao PS. Diagnosis and management of cyanotic congenital heart disease: part I. Indian J Pediatr 2009;76:57-70.

17) Shrivastava S. Blue babies: when to intervene. Indian J Pediatr 2005;72:599-602.

18) Flick RP, Wilder RT, Pieper SF, van Koeverden K, Ellison KM, Marienau ME, et al. Risk factors for laryngospasm in children during general anesthesia. Paediatr Anaesth 2008;18:289-96.

19) Kasar T, Tanıdır İC, Öztürk E, Gökalp S, Tunca Şahin G, Topkarcı MA, et al. Arrhythmia during diagnostic cardiac catheterization in pediatric patients with congenital heart disease. Turk Kardiyol Dern Ars 2018;46:675-82.

20) Tokel K, Gümüş A, Ayabakan C, Varan B, Erdoğan İ. Complications of cardiac catheterization in children with congenital heart disease. Turk J Pediatr 2018;60:675-83.

21) Bergersen L, Gauvreau K, Jenkins KJ, Lock JE. Adverse event rates in congenital cardiac catheterization: a new understanding of risks. Congenit Heart Dis 2008;3:90-105.

22) Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S, et al. Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv 2010;75:389-400.

23) Backes CH, Bergersen L, Rome JJ, Batlivala SP, Glatz AC, Ovunc B, et al. Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality. Catheter Cardiovasc Interv 2015;85:104-10.

24) Mori Y, Takahashi K, Nakanishi T. Complications of cardiac catheterization in adults and children with congenital heart disease in the current era. Heart Vessels 2013;28:352-9.

25) Moore JW, Vincent RN, Beekman RH 3rd, Benson L, Bergersen L, Holzer Ret al. Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry. J Am Coll Cardiol 2014;64:2439-51.

26) Qawasmeh Y, Hijazi I, Altarawneh H, Almomani A, Abu Haweleh A. Interventional cardiac catheterization In Congenital Heart Disease: Experience at Queen Alia Heart Institute. JRMS 2018;25:64-7.